CD63 and soft tissue sarcoma: Since we demonstrated that there are no significant differences in CD62P- and CD63-positive microvesicles between the different soft tissue sarcoma grades (Fig. 2), we consider the significant differences between the groups with and without a history of VTE (Fig. 3) to be related to the patients’ positive history of VTE rather than to the grading of the tumor.